2020
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, Bacon S, Hulme W, Bates C, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson L, Mathur R, Wing K, Wong AYS, Forbes H, Parry J, Hester F, Harper S, Evans SJW, Quint J, Smeeth L, Douglas IJ, Goldacre B, Collaborative O. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. The Lancet Respiratory Medicine 2020, 8: 1106-1120. PMID: 32979987, PMCID: PMC7515601, DOI: 10.1016/s2213-2600(20)30415-x.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, InhalationAdolescentAdrenal Cortex HormonesAdultAgedAged, 80 and overAsthmaBetacoronavirusCohort StudiesCoronavirus InfectionsCOVID-19Electronic Health RecordsEnglandFemaleHumansMaleMiddle AgedMuscarinic AntagonistsPandemicsPneumonia, ViralProportional Hazards ModelsPulmonary Disease, Chronic ObstructiveRegression AnalysisSARS-CoV-2Young AdultConceptsChronic obstructive pulmonary diseaseCOVID-19-related deathsIndex dateObstructive pulmonary diseaseElectronic health recordsOpenSAFELY platformRespiratory medicationsCOPD cohortHazard ratioPulmonary diseaseAsthma cohortPrimary care electronic health recordsSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2High-dose ICSHigh-dose ICSsRegular ICS useΒ-agonistsObservational cohort studyUK Medical Research CouncilRisk of deathCox regression modelAcute respiratory diseaseSyndrome coronavirus 2
2018
Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011–2015 - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC
Kajon AE, Lamson DM, Bair CR, Lu X, Landry ML, Menegus M, Erdman DD, St. George K. Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011–2015 - Volume 24, Number 2—February 2018 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2018, 24: 201-209. PMID: 29350143, PMCID: PMC5782899, DOI: 10.3201/eid2402.171407.Peer-Reviewed Original ResearchConceptsAcute respiratory diseaseCivilian adultsInfectious Diseases journal - CDCUS military recruitsLong-term care facilitiesInfluenza-like illnessAdenovirus type 4Respiratory infectionsHuman adenovirus type 4Vaccination protocolsCancer patientsHAdV-4Respiratory diseasePhysician's officeCare facilitiesNursing homesMilitary recruitsVaccine strainYoung adultsType 4Causative agentAdultsLike variantsMilitary settingsDetailed molecular characterization
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply